91 257 00 03 Chamada para a rede móvel nacional info@formiventos.com

FDA is issuing this draft guidance to provide recommendations on computer software assurance  for computers and automated data processing systems used as part of medical device production  or the quality system.


This draft guidance is intended to:

 · Describe “computer software assurance” as a risk-based approach to establish confidence  in the automation used for production or quality systems, and identify where additional  rigor may be appropriate; and 

· Describe various methods and testing activities that may be applied to establish computer  software assurance and provide objective evidence to fulfill regulatory requirements,  such as computer software validation requirements in 21 CFR part 820 (Part 820).

 When final, this guidance will supplement FDA’s guidance, “General Principles of Software Validation” (“Software Validation guidance”)2  except this guidance will supersede Section 6  (“Validation of Automated Process Equipment and Quality System Software”) of the Software  Validation guidance.